ArticleNPP - digital psychiatry and neuroscience2026
A probabilistic deep learning approach for choroid plexus segmentation in autism spectrum disorder.
Article in NPP - digital psychiatry and neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The choroid plexus serves as the primary barrier between the brain's blood and cerebrospinal fluid and mediates neuroimmune function. A subset of individuals with autism spectrum disorder (ASD) may exhibit morphological alterations of the choroid plexus. However, to power larger population analyses, an automated tool capable of accurately segmenting the choroid plexus based on magnetic resonance imaging (MRI) is needed. Automated Segmentation of CHOroid PLEXus (ASCHOPLEX) is a deep learning tool that enables finetuning using new, patient-specific, training data, allowing its usage across cohorts for which the model was not originally trained. We evaluated ASCHOPLEX's generalizability to individuals with ASD by performing finetuning on a local dataset of ASD and control (CON) participants. To assess generalizability, we implemented a probabilistic version of the algorithm, which allowed us to quantify the uncertainty in choroid plexus segmentation and evaluate the model's confidence. ASCHOPLEX generalized well to our local dataset, in which all participants were adults. To further assess its performance, we tested the algorithm on the Autism Brain Imaging Data Exchange (ABIDE) dataset, which includes data from children and adults. While ASCHOPLEX performed well in adults, its accuracy declined in children, suggesting limited generalizability to different age groups without additional finetuning. Our findings show that the incorporation of a probabilistic approach during finetuning can strengthen the use of this deep learning tool by providing confidence metrics which allow assessing model reliability. Overall, our findings demonstrate that ASCHOPLEX can generate accurate choroid plexus segmentations in previously unseen data.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.